30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Corium International Inc (CORI)

Track

Stock chart
Ticker: CORI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gurnet Holding Co
2 purchases — total 457,868,813 USD
Buy 27 Nov 2018
Value US$3,570,803.76 | Price 167.69 | Shares 75,154
Buy 27 Nov 2018
Value US$1,212,741.17 | Price 93.11 | Shares 43,181
Sale 12 Oct 2018
Value US$3,322,339.77 | Price 427.78 | Shares 22,220
Sale 12 Oct 2018
Value US$638,651.14 | Price 396.33 | Shares 20,493
Sale 11 Oct 2018
Value US$6,250,000.00 | Price 12.50 | Shares 500,000
Sale 11 Oct 2018
Value US$3,533,411.97 | Price 12.51 | Shares 282,447
Sale 17 Aug 2018
Value US$3,116.98 | Price 9.01 | Shares 346
Sale 17 Aug 2018
Value US$28,223.94 | Price 9.01 | Shares 3,133
Sale 17 Aug 2018
Value US$8,756.36 | Price 9.01 | Shares 972
Sale 17 Aug 2018
Value US$32,115.66 | Price 9.01 | Shares 3,565
Planned sale 17 Aug 2018
Value US$307,586.14 | Price 8.96 | Shares 34,320
Sale 17 Aug 2018
Value US$24,332.23 | Price 9.01 | Shares 2,701
Planned sale 16 Aug 2018
Value US$340,605.57 | Price 8.66 | Shares 39,320
Planned sale 15 Aug 2018
Value US$315,476.20 | Price 8.86 | Shares 35,608
Buy 18 Jan 2018
Value US$3,968,000.00 | Price 12.80 | Shares 310,000
Buy 17 Jan 2018
Value US$1,831,716.00 | Price 12.24 | Shares 149,650
Buy 16 Jan 2018
Value US$595,640.50 | Price 11.83 | Shares 50,350
Sale 17 Nov 2017
Value US$273,750.00 | Price 10.95 | Shares 25,000
Sale 17 Nov 2017
Value US$101,434.80 | Price 10.96 | Shares 9,255
Sale 17 Nov 2017
Value US$1,095,000.00 | Price 10.95 | Shares 100,000
Sale 17 Nov 2017
Value US$719,448.45 | Price 11.01 | Shares 65,345
Sale 16 Nov 2017
Value US$4,388.00 | Price 10.97 | Shares 400
Sale 16 Nov 2017
Value US$272,000.00 | Price 10.88 | Shares 25,000
Sale 16 Nov 2017
Value US$271,250.00 | Price 10.85 | Shares 25,000
Sale 16 Nov 2017
Value US$2,742,500.00 | Price 10.97 | Shares 250,000
Sale 2 Nov 2017
Value US$1,657,500.00 | Price 11.05 | Shares 150,000
Sale 4 Oct 2017
Value US$2,401,106.52 | Price 11.01 | Shares 218,100
Sale 22 Aug 2017
Value US$173,561.31 | Price 7.61 | Shares 22,822
Sale 21 Aug 2017
Value US$57,138.84 | Price 7.53 | Shares 7,593
Sale 17 Aug 2017
Value US$91,529.04 | Price 7.62 | Shares 12,012
Sale 17 Aug 2017
Value US$243,619.20 | Price 7.61 | Shares 32,000
Sale 16 Aug 2017
Value US$121,156.43 | Price 7.82 | Shares 15,488
Planned sale 20 Jul 2017
Value US$18,232.36 | Price 8.95 | Shares 2,038
Buy 30 Jun 2017
Value US$2,319,235.82 | Price 7.71 | Shares 301,004
Buy 25 May 2017
Value US$11,890,000.00 | Price 6.25 | Shares 1,902,400
Buy 19 May 2016
Value US$23,453.46 | Price 3.70 | Shares 6,341
Buy 19 May 2016
Value US$28,879.09 | Price 3.71 | Shares 7,790
Buy 18 May 2016
Value US$20,178.86 | Price 3.57 | Shares 5,659
Buy 18 May 2016
Value US$16,688.47 | Price 3.54 | Shares 4,710
Buy 16 May 2016
Value US$24,046.10 | Price 3.70 | Shares 6,500
Buy 13 May 2016
Value US$20,995.80 | Price 3.50 | Shares 6,000
Buy 12 May 2016
Value US$10,742.40 | Price 3.58 | Shares 3,000
Buy 25 Feb 2015
Value US$25,169.04 | Price 6.99 | Shares 3,600
Buy 24 Nov 2014
Value US$8,640.00 | Price 5.40 | Shares 1,600
Buy 21 Nov 2014
Value US$48,054.60 | Price 5.34 | Shares 9,000
Buy 27 Aug 2014
Value US$1,860.00 | Price 6.20 | Shares 300
Buy 26 Aug 2014
Value US$6,143.50 | Price 6.14 | Shares 1,000
Buy 25 Aug 2014
Value US$7,725.51 | Price 6.05 | Shares 1,278
Buy 30 May 2014
Value US$16,982.40 | Price 7.08 | Shares 2,400
Buy 29 May 2014
Value US$20,518.08 | Price 7.08 | Shares 2,900
Buy 28 May 2014
Value US$13,205.57 | Price 6.95 | Shares 1,900
Buy 8 Apr 2014
Value US$3,200,000.00 | Price 8.00 | Shares 400,000
Buy 8 Apr 2014
Value US$3,200,000.00 | Price 8.00 | Shares 400,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-28 2018-11-27 B Purchase Gurnet Holding Co Large shareholder
75,154 -20.0%
167.69
US$3,570,804 		75,154 -20.0% 167.69 US$3,570,804
2018-11-28 2018-11-27 B Purchase Gurnet Holding Co Large shareholder
43,181 -10.4%
93.11
US$1,212,741 		43,181 -10.4% 93.11 US$1,212,741
2018-10-15 2018-10-12 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
22,220 -2.9%
427.78
US$3,322,340 		22,220 -2.9% 427.78 US$3,322,340
2018-10-15 2018-10-12 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
500,000 -9.0%
12.51
US$6,255,000 		500,000 -9.0% 12.51 US$6,255,000
2018-10-15 2018-10-11 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
500,000 -8.2%
12.50
US$6,250,000 		500,000 -8.2% 12.50 US$6,250,000
2018-10-15 2018-10-11 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
282,447 -4.4%
12.51
US$3,533,412 		282,447 -4.4% 12.51 US$3,533,412
2018-08-17 2018-08-17 S Sale Sweemer Timothy D

Chief Accounting Officer

Officer
346 -1.0%
9.01
US$3,117 		346 -1.0% 9.01 US$3,117
2018-08-17 2018-08-17 S Sale Singh Parminder

CTO & Vice President, R&D

Officer
3,133 -16.5%
9.01
US$28,224 		3,133 -16.5% 9.01 US$28,224
2018-08-17 2018-08-17 S Sale BREUIL ROBERT S

Chief Financial Officer

Officer
972 -6.3%
9.01
US$8,756 		972 -6.3% 9.01 US$8,756
2018-08-17 2018-08-17 S Sale Sarret Joseph J.

Chief Business Officer

Officer
3,565 -18.0%
9.01
US$32,116 		3,565 -18.0% 9.01 US$32,116
2018-08-17 2018-08-17 PlS Planned sale STAPLE PETER D

President & CEO

Executive Director
34,320 -12.2%
8.96
US$307,586 		34,320 -12.2% 8.96 US$307,586
2018-08-17 2018-08-17 S Sale STAPLE PETER D

President & CEO

Executive Director
2,701 -0.9%
9.01
US$24,332 		2,701 -0.9% 9.01 US$24,332
2018-08-17 2018-08-16 PlS Planned sale STAPLE PETER D

President & CEO

Executive Director
39,320 -12.4%
8.66
US$340,606 		39,320 -12.4% 8.66 US$340,606
2018-08-17 2018-08-15 PlS Planned sale Thomas Robert Non-Executive Director
35,608 -100.0%
8.86
US$315,476 		35,608 -100.0% 8.86 US$315,476
2018-01-18 2018-01-18 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
310,000 +5.1%
12.80
US$3,968,000 		310,000 +5.1% 12.80 US$3,968,000
2018-01-18 2018-01-17 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
149,650 +2.5%
12.24
US$1,831,716 		149,650 +2.5% 12.24 US$1,831,716
2018-01-18 2018-01-16 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
50,350 +0.9%
11.83
US$595,640 		50,350 +0.9% 11.83 US$595,640
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.95
US$273,750 		25,000 -0.7% 10.95 US$273,750
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
9,255 -0.3%
10.96
US$101,435 		9,255 -0.3% 10.96 US$101,435
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -2.7%
10.95
US$1,095,000 		100,000 -2.7% 10.95 US$1,095,000
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
65,345 -1.7%
11.01
US$719,448 		65,345 -1.7% 11.01 US$719,448
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
400 -0.0%
10.97
US$4,388 		400 -0.0% 10.97 US$4,388
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.88
US$272,000 		25,000 -0.7% 10.88 US$272,000
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.85
US$271,250 		25,000 -0.7% 10.85 US$271,250
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
250,000 -6.1%
10.97
US$2,742,500 		250,000 -6.1% 10.97 US$2,742,500
2017-11-03 2017-11-02 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
150,000 -3.6%
11.05
US$1,657,500 		150,000 -3.6% 11.05 US$1,657,500
2017-10-06 2017-10-04 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
218,100 -4.9%
11.01
US$2,401,107 		218,100 -4.9% 11.01 US$2,401,107
2017-08-23 2017-08-22 S Sale Singh Parminder

CTO & Vice President, R&D
22,822 -74.2%
7.61
US$173,561 		22,822 -74.2% 7.61 US$173,561
2017-08-23 2017-08-21 S Sale Singh Parminder

CTO & Vice President, R&D
7,593 -19.8%
7.53
US$57,139 		7,593 -19.8% 7.53 US$57,139
2017-08-18 2017-08-17 S Sale Sweemer Timothy D

Chief Accounting Officer
12,012 -27.1%
7.62
US$91,529 		12,012 -27.1% 7.62 US$91,529
2017-08-18 2017-08-17 S Sale Singh Parminder

CTO & Vice President, R&D
32,000 -45.5%
7.61
US$243,619 		32,000 -45.5% 7.61 US$243,619
2017-08-18 2017-08-16 S Sale Sweemer Timothy D

Chief Accounting Officer
15,488 -25.9%
7.82
US$121,156 		15,488 -25.9% 7.82 US$121,156
2017-07-21 2017-07-20 PlS Planned sale Sarret Joseph J.

Chief Business Officer

Officer
2,038 -21.5%
8.95
US$18,232 		2,038 -21.5% 8.95 US$18,232
2017-07-05 2017-06-30 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
301,004 +5.4%
7.71
US$2,319,236 		301,004 +5.4% 7.71 US$2,319,236
2017-05-25 2017-05-25 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
1,902,400 +52.2%
6.25
US$11,890,000 		1,902,400 +52.2% 6.25 US$11,890,000
2016-05-20 2016-05-19 B Purchase BJERKHOLT ERIC Non-Executive Director
6,341 +112.1%
3.70
US$23,453 		6,341 +112.1% 3.70 US$23,453
2016-05-20 2016-05-19 B Purchase BJERKHOLT ERIC Non-Executive Director
7,790 +165.4%
3.71
US$28,879 		7,790 +165.4% 3.71 US$28,879
2016-05-20 2016-05-18 B Purchase BJERKHOLT ERIC Non-Executive Director
5,659 +inf%
3.57
US$20,179 		5,659 +inf% 3.57 US$20,179
2016-05-20 2016-05-18 B Purchase BJERKHOLT ERIC Non-Executive Director
4,710 +inf%
3.54
US$16,688 		4,710 +inf% 3.54 US$16,688
2016-05-17 2016-05-16 B Purchase STAPLE PETER D

President & CEO

Executive Director
6,500 +22.9%
3.70
US$24,046 		6,500 +22.9% 3.70 US$24,046
2016-05-17 2016-05-13 B Purchase STAPLE PETER D

President & CEO

Executive Director
6,000 +26.8%
3.50
US$20,996 		6,000 +26.8% 3.50 US$20,996
2016-05-16 2016-05-12 B Purchase GREENWOOD DAVID Non-Executive Director
3,000 +inf%
3.58
US$10,742 		3,000 +inf% 3.58 US$10,742
2015-02-26 2015-02-25 B Purchase STAPLE PETER D

President & CEO

Executive Director
3,600 +19.2%
6.99
US$25,169 		3,600 +19.2% 6.99 US$25,169
2014-11-24 2014-11-24 B Purchase BREUIL ROBERT S

Chief Financial Officer

Officer
1,600 +40.0%
5.40
US$8,640 		1,600 +40.0% 5.40 US$8,640
2014-11-24 2014-11-21 B Purchase STAPLE PETER D

President & CEO

Executive Director
9,000 +92.0%
5.34
US$48,055 		9,000 +92.0% 5.34 US$48,055
2014-08-27 2014-08-27 B Purchase STAPLE PETER D

President & CEO

Executive Director
300 +3.2%
6.20
US$1,860 		300 +3.2% 6.20 US$1,860
2014-08-27 2014-08-26 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,000 +11.8%
6.14
US$6,144 		1,000 +11.8% 6.14 US$6,144
2014-08-27 2014-08-25 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,278 +17.8%
6.05
US$7,726 		1,278 +17.8% 6.05 US$7,726
2014-05-30 2014-05-30 B Purchase STAPLE PETER D

President & CEO

Executive Director
2,400 +50.0%
7.08
US$16,982 		2,400 +50.0% 7.08 US$16,982
2014-05-30 2014-05-29 B Purchase STAPLE PETER D

President & CEO

Executive Director
2,900 +152.6%
7.08
US$20,518 		2,900 +152.6% 7.08 US$20,518
2014-05-30 2014-05-28 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,900 +inf%
6.95
US$13,206 		1,900 +inf% 6.95 US$13,206
2014-04-08 2014-04-08 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
400,000 +4.5%
8.00
US$3,200,000 		400,000 +4.5% 8.00 US$3,200,000
2014-04-08 2014-04-08 B Purchase Eastman Ronald W Non-Executive Director Large shareholder
400,000 +4.5%
8.00
US$3,200,000 		400,000 +4.5% 8.00 US$3,200,000
Explore more

More insider trading research around Corium International Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America